Clinical Trial Update: The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction [Phase 1]

View source ↗

Summary

Phase 1 clinical trial examining the effects of endothelin and L-arginine on racial differences in vasoconstriction has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Endothelin (Endothelin)
• L-Arginine (L-Arginine)

Snippet

Sponsor: The University of Texas at Arlington | Conditions: Cardiovascular Diseases, Cardiovascular Risk Factor | Phase 1 | Status: COMPLETED